A detailed history of Madison Avenue Partners, LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 8,511,350 shares of TBPH stock, worth $73.6 Million. This represents 12.2% of its overall portfolio holdings.

Number of Shares
8,511,350
Previous 7,012,226 21.38%
Holding current value
$73.6 Million
Previous $62.9 Million 14.75%
% of portfolio
12.2%
Previous 12.55%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$8.29 - $9.92 $12.4 Million - $14.9 Million
1,499,124 Added 21.38%
8,511,350 $72.2 Million
Q3 2022

Nov 14, 2022

SELL
$8.39 - $10.22 $2.16 Million - $2.63 Million
-257,358 Reduced 3.54%
7,012,226 $71.1 Million
Q1 2022

May 16, 2022

BUY
$8.33 - $12.96 $5.18 Million - $8.06 Million
621,559 Added 9.35%
7,269,584 $69.5 Million
Q4 2021

Feb 14, 2022

BUY
$7.42 - $11.05 $12.8 Million - $19 Million
1,718,602 Added 34.86%
6,648,025 $73.5 Million
Q3 2021

Nov 15, 2021

BUY
$6.77 - $14.41 $33.4 Million - $71 Million
4,929,423 New
4,929,423 $36.5 Million

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $578M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Madison Avenue Partners, LP Portfolio

Follow Madison Avenue Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Avenue Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Madison Avenue Partners, LP with notifications on news.